I CAN Act
Summary
The I CAN Act (HR1317) structurally lowers healthcare labor costs by expanding APRN scope under Medicare/Medicaid, directly benefiting managed care insurers. Real market data confirms managed-care insurers $CNC (+27.93% 7-day, +63.41% 30-day), $MOH (+10.81% 7-day, +46.26% 30-day), and $HUM (+12.05% 7-day, +39.09% 30-day) are already pricing in this regulatory tailwind. The bill is early-stage but has a companion in the Senate and executive-order tailwinds — pure-play Medicaid/Medicare insurers are the structural winners.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.I CAN Act (HR1317) removes physician-only requirements for inpatient certifications, rehab supervision, and skilled nursing care under Medicare/Medicaid — structurally lowering insurer labor costs without new spending
- 2.Pure-play government insurers $CNC (+27.93% 7-day, +63.41% 30-day), $MOH (+10.81%, +46.26%), and $HUM (+12.05%, +39.09%) show concentrated investor recognition of margin improvement in their core Medicare/Medicaid books
- 3.Companion bill S575 advancing in Senate and April 18 executive order create parallel regulatory tailwinds; passage probability elevated for an early-stage bill
Market Implications
Market data confirms investors are already pricing in APRN scope expansion for pure-play government insurers. $CNC at $53.50 (from $38.17 on April 17) and $MOH at $194.96 (from $148.97) show speculative positioning ahead of legislative progress. These stocks have high beta to any incremental news on I CAN Act movement — committee hearings, cosponsor additions, or Senate markups will likely drive further upside. Diversified insurers $UNH ($366.39) and $CVS ($83.33) have more muted reactions and lower structural leverage to this specific bill due to their commercial insurance and retail/pharmacy revenue. For investors tracking this legislative theme, focus on committee scheduling for HR1317 and S575 floor votes — those are the next catalysts. The structural margin improvement (1-3% MCR reduction for pure plays) supports current valuation levels and provides a fundamental floor even if the bill stalls, as executive rulemaking provides partial scope expansion regardless.
Full Analysis
The I CAN Act (HR1317) was introduced on February 13, 2025 by Rep. David Joyce (R-OH) with 30 cosponsors. It has been referred to both the House Committee on Energy and Commerce and the Committee on Ways and Means — two powerful committees that control healthcare and tax policy. An identical companion bill, S575, is advancing in the Senate (read twice, referred to Committee on Finance). The bill is early-stage, but the Senate companion and a bipartisan cosponsor list (including both Republicans and Democrats) signal above-average momentum for a scope-of-practice expansion bill. Bill text confirms the bill removes physician-only requirements for: inpatient hospital certification (Sec. 107), cardiac/pulmonary rehab supervision (Sec. 101), diabetic shoe documentation (Sec. 102), and skilled nursing facility care (Sec. 107). The bill authorizes zero direct spending — it changes who CAN provide services, not direct payment levels. This is a regulatory relief mechanism that structurally lowers insurer costs by reducing physician wage dependency.
The money trail flows through insurer medical cost ratios (MCR). Every certification, supervision, and documentation function shifted from a physician (median $240K/year) to an APRN (median $120K/year) represents a ~50% labor cost reduction per function. For managed care organizations processing millions of claims annually, this aggregates to material savings. The April 18 mental health executive order further amplifies APRN utilization, creating parallel regulatory tailwinds that compound the bill's effects even before passage — insurers can begin structuring networks anticipating reduced physician bottlenecks.
Structural winners are pure-play government-sponsored insurers whose revenue is concentrated in Medicare Advantage and Medicaid. $CNC (Centene) surged 27.93% in 7 days and 63.41% in 30 days, reaching $53.50 on April 30. $MOH (Molina) rose 10.81% and 46.26% over the same periods, closing at $194.96. $HUM (Humana) gained 12.05% and 39.09%, closing at $241.17. These outsized moves — significantly outperforming broad market averages — reflect concentrated investor recognition that APRN flexibilities directly improve margins on their core businesses. $UNH (UnitedHealth Group) +3.23% 7-day and +35.4% 30-day, and $CVS (CVS Health) +6.92% and +16.03%, show positive but more muted reactions given their diversified revenue bases (Optum pharmacy/health services and CVS pharmacy retail, respectively).
Timeline: The bill is early-stage in the House but S575 has a more advanced status in the Senate. The 119th Congress runs through January 2027, giving two more years for committee markups, floor votes, and potential reconciliation. Executive branch rulemaking via mental health executive order provides parallel regulatory progress. Passage probability increases with each committee hearing and endorsement from insurer trade groups (AHIP, Medicaid Health Plans of America). The pure-play insurers ($CNC, $MOH, $HUM) have the highest structural exposure and are the clearest beneficiaries regardless of exact passage timeline.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
What the bill does
Expansion of APRN scope under Medicare/Medicaid to perform certifications, supervision, and documentation tasks previously requiring physicians, reducing labor costs per insured member
Who must act
Managed care organizations (Centene) administering Medicare Advantage and Medicaid plans
What happens
Lower physician-salary dependency per beneficiary for administrative and supervisory functions, structurally reducing medical cost ratio by an estimated 1-3% for members served in cost-sensitive Medicaid/Medicare populations
Stock impact
Centene serves ~28 million Medicaid and Medicare members via Ambetter and Medicare Advantage plans; APRN flexibilities directly lower its medical cost ratio (MCR), improving margin on its highest-volume, lowest-premium business — the core margin driver for this pure-play insurer
What the bill does
Expansion of APRN scope under Medicare/Medicaid to allow nurse practitioners to certify inpatient hospital stays and supervise rehab programs, reducing physician referral bottlenecks
Who must act
Molina Healthcare's managed care plans in Medicaid and Medicare dual-eligible markets
What happens
Reduced administrative overhead and faster patient throughput in safety-net hospital networks, lowering Molina's per-member administrative and medical costs by an estimated 1-2%
Stock impact
Molina is a pure-play Medicaid/Medicare dual-eligible insurer with ~5.4 million members; APRN flexibilities directly improve margins on its core government-sponsored insurance book, where cost control is the competitive differentiator
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Association Health Plans Act
Protecting Health Care and Lowering Costs Act of 2025
Medicare for All Act
Putting Patients First Healthcare Freedom Act
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
TRIWEST HEALTHCARE ALLIANCE CORP: $929M Department of Veterans Affairs Contract
Consolidated Appropriations Act, 2026
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →